↑ 薬物リストへ　← 戻る

Bisoprolol    (DrugBank: Bisoprolol)

3 diseases
告示番号疾患名（ページ内リンク）臨床試験数
67多発性嚢胞腎0
86肺動脈性肺高血圧症2
113筋ジストロフィー1

67. 多発性嚢胞腎　［臨床試験数：186，薬物数：196（DrugBank：47），標的遺伝子数：35，標的パスウェイ数：146］
Searched query = "Polycystic kidney disease", "PKD", "PCKD", "Polycystic kidney", "ADPKD", "ARPKD"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 186 trial found

86. 肺動脈性肺高血圧症　［臨床試験数：1,083，薬物数：667（DrugBank：122），標的遺伝子数：98，標的パスウェイ数：185］
Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 1,083 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01246037
(ClinicalTrials.gov)		February 201118/11/2010Beta-blockers in i-PAHBeta-blocker Therapy in Idiopathic Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionDrug: BisoprololVU University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentActive, not recruiting18 YearsN/ABoth30Phase 1;Phase 2Netherlands
2EUCTR2010-020424-21-NL
(EUCTR)		10/01/201130/08/2010Betablocker Therapy in Pulmonary Arterial HypertensionBetablocker Therapy in Pulmonary Arterial Hypertension Idiopathic pulmonal arterial hypertension
MedDRA version: 12.1;Level: LLT;Classification code 10020787;Term: Hypertension pulmonary		Product Name: Bisoprolol
Product Code: C07AB07		VU medical centerNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		Netherlands

113. 筋ジストロフィー　［臨床試験数：567，薬物数：442（DrugBank：93），標的遺伝子数：55，標的パスウェイ数：151］
Searched query = "Muscular dystrophy", "Dystrophinopathies", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "Rigid spine syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 567 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03779646
(ClinicalTrials.gov)		January 16, 201914/12/2018Bisoprolol in DMD Early CardiomyopathyBisoprolol for Early Cardiomyopathy in Duchenne Muscular Dystrophy: a Randomized, Controlled TrialDuchenne Muscular Dystrophy;Cardiomyopathy, DilatedDrug: Bisoprolol FumaratePeking Union Medical College HospitalNational Natural Science Foundation of China;Chinese Academy of Medical SciencesRecruiting7 YearsN/AMale42Phase 2;Phase 3China